home / stock / xbio / xbio short
Short Information | Xenetic Biosciences Inc. (NASDAQ:XBIO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 27,549 |
Total Actual Volume | 142,858 |
Short Trends | |
---|---|
Cover Days | 17 |
Short Days | 0 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 1,377 |
Average Short Percentage | 20.20% |
Is there a XBIO Short Squeeze or Breakout about to happen?
See the XBIO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-28-2024 | $3.8965 | $3.77 | $3.8999 | $3.77 | 3,449 | 1,136 | 32.94% |
03-27-2024 | $3.96 | $3.98 | $4.17 | $3.96 | 9,311 | 3,644 | 39.14% |
03-26-2024 | $3.99 | $3.82 | $4 | $3.77 | 4,818 | 1,631 | 33.85% |
03-25-2024 | $3.76 | $3.95 | $4 | $3.75 | 8,852 | 308 | 3.48% |
03-22-2024 | $3.65 | $3.86 | $3.9638 | $3.65 | 2,900 | 1 | 0.03% |
03-21-2024 | $4.25 | $3.95 | $4.25 | $3.93 | 17,381 | 1,855 | 10.67% |
03-20-2024 | $4.21 | $4.2 | $4.21 | $4.1724 | 3,264 | 201 | 6.16% |
03-19-2024 | $4.25 | $4.25 | $4.35 | $4.25 | 1,279 | 360 | 28.15% |
03-18-2024 | $4.36 | $4.25 | $4.36 | $4.03 | 4,266 | 453 | 10.62% |
03-15-2024 | $4.2 | $4.35 | $4.38 | $4.112 | 4,642 | 1,538 | 33.13% |
03-14-2024 | $4.27 | $4.1851 | $4.4 | $4.18 | 9,746 | 2,139 | 21.95% |
03-13-2024 | $3.97 | $4.17 | $4.4 | $3.97 | 6,089 | 1,295 | 21.27% |
03-12-2024 | $4.09 | $4 | $4.09 | $3.96 | 997 | 112 | 11.23% |
03-11-2024 | $4.05 | $4.28 | $4.3 | $4.04 | 8,970 | 444 | 4.95% |
03-08-2024 | $3.774 | $4.0698 | $4.25 | $3.7671 | 8,960 | 3,505 | 39.12% |
03-07-2024 | $4.085 | $3.98 | $4.1173 | $3.98 | 3,902 | 1,258 | 32.24% |
03-06-2024 | $4.42 | $4.2316 | $4.42 | $4.2316 | 685 | 252 | 36.79% |
03-05-2024 | $4.11 | $4.0901 | $4.12 | $4.09 | 1,908 | 5 | 0.26% |
03-04-2024 | $4.47 | $4.05 | $4.49 | $3.9001 | 13,685 | 3,077 | 22.48% |
03-01-2024 | $4.16 | $4.35 | $4.4761 | $4.1336 | 27,754 | 4,335 | 15.62% |
News, Short Squeeze, Breakout and More Instantly...
Xenetic Biosciences Inc. Company Name:
XBIO Stock Symbol:
NASDAQ Market:
Xenetic Biosciences Inc. Website:
Continued advancement of DNase-based oncology program towards Phase 1 clinical study for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Ended the year with $9.0 million of cash to fund operations FRAMINGHAM, MA / ACCESSWIRE / March 22, 2024 /...
- Company building growing body of preclinical data to guide pathway to first in human trial for DNase-based oncology platform FRAMINGHAM, MA / ACCESSWIRE / January 17, 2024 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advan...
Encouraging growing body of preclinical data guiding pathway to first in human trial for DNase-based oncology platform Driving development towards Phase 1 program for the treatment of pancreatic carcinoma and other locally advanced or metastatic solid tumors Continuing partnering discus...